Skip to content

Solventum SOLV Remainder of 2026

Remainder of 2026 at other companies

3M logo
3MMMM
Cardinal Health logo
Cardinal HealthCAH
Align Technology logo
Align TechnologyALGN
Globus Medical logo
Globus MedicalGMED
Medline, Inc.
 logo
Medline, Inc. MDLN
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's remainder of 2026?
Solventum (SOLV) reported remainder of 2026 of $270M in Q1 2026.
How has Solventum's remainder of 2026 changed year-over-year?
Solventum's remainder of 2026 increased by 18.4% year-over-year, from $228M to $270M.